Michael P. Tarnok, Director at KERYX BIOPHARMACEUTICALS INC (KERX), bought 40,000 shares at $0.46 ($18K) on 2009-05-26, disclosed to the SEC on 2009-05-27.
Open-market purchase of $18k KERX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KERX | BUY | 2011-08-11 | $47K | — | Filing → |
| KERX | BUY | 2007-11-20 | $10K | — | Filing → |